Speaker Biography

Ramamurthy Subramaniam

HOD Aesthetic Academy Asia ,Malaysia

Title: Treatment Protocol for Vascular Occlusion Following Soft Tissue Filler Augmentation

Ramamurthy Subramaniam

He is one of Asia’s most sought after Aesthetic Medicine trainer and Business Coach. He has lectured in world-renowned Aesthetic Societies and Academy organizations – Australia, US, England, Korea, Thailand, Indonesia, Malaysia, and Singapore. His training includes Aesthetic Medicine, Clinical Skills and Business Development. He designed several curriculums and was the Head of Department for several Aesthetic Academies’ in Malaysia. He is currently appointed as the Chairperson for AAA.


Superficial dermal fillers have become increasingly popular in recent years, primarily because of their multiple aesthetic uses, especially in the facial region. They have been used to re-volumize depleted facial fat compartments, reduce facial lines and folds, enhance facial features such as nose, lip and chin augmentation, among others. These procedures are becoming increasingly popular due to its low cost, immediate satisfactory result and with almost no recovery time. According to the American Society for Aesthetic Plastic Surgery, more than 2 million hyaluronic acid (HA) dermal filler procedures were performed in 2016, an increase of 3% from 2015. With the increased demand and availability of artificial soft tissue filler materials, there has been a plethora of increased adverse effects as well. One of the most significant adverse events associated with injections of soft tissue augmentation products is vascular occlusion. Other unwanted effects ranges from erythema, granuloma, necrosis, acute blindness, stroke, including death. This may probably be due to lack of knowledge, training or skills. Aesthetic physicians who administer soft tissue augment products should have a thorough understanding of facial vascular anatomy, as well as the effects of different available products, potential complications and treatment options. This presentation will describe the pathogenesis of vascular occlusion following soft tissue augmentation procedures and its treatment options.